A Biological License Application (BLA) is the FDA submission required to obtain approval to market a biologic product in the United States.
A BLA contains clinical, nonclinical, and manufacturing data demonstrating safety, purity, and potency. FDA review evaluates benefitñrisk balance and production controls. Successful approval permits commercial distribution of vaccines, gene therapies, and other biologics.